THE Pharmaceutical Society of Australia (PSA) is inviting feedback on revised guidelines for Dose Administration Aid services, following a review to support the implementation of new Professional Practice Standards.
The review has focused on Standard 15: Dose Administration Aid (DAA) Service, undertaken to take into account recent research, changes to common practices and the release of the Guidelines on dose administration aids and staged supply of dispensed medicines by the Pharmacy Board of Australia in September 2015.
Comments are sought from stakeholders including pharmacists, consumers, other health professional groups and practitioners, educators, researchers and government bodies.
An important outcome of the review has been updating of the guidance around cytotoxic medicines and medicines stability when repacked in a DAA, in line with recommendations from the Pharmacy Board, as well as Australian and international literature.
The revised guidelines also address advancements in automated packing technology that have developed since the last review in 2007.
The PSA acknowledges the Federal Department of Health for providing funding for this work as part of the PBS Access and Sustainability Package, including the Sixth Community Pharmacy Agreement (6CPA).
Visit psa.org.au to access the consultation paper, including the revised DAA Guidelines.
The consultation will remain open until 24 May 2017 - CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 May 17